Showing results (2731-2740 of 3,717) with videos related to
Sort By:
Pageof 372
Investigational New Drugs|October 21, 2023
Gastrointestinal signet ring cell malignancy: current advancement and future prospectsWeiping Hong, Qingjun Hu, Yuan Tan, et al.Investigational New Drugs|October 30, 2023
Clinical characteristics and prognostic impact of immune checkpoint inhibitor-associated myocarditis in advanced non-small cell lung cancerLan Xu, Manyi Xu, Wei Sun, et al.Investigational New Drugs|March 27, 2024
Effect of early dose reduction of osimertinib on efficacy in the first-line treatment for EGFR-mutated non-small cell lung cancerTomoki Hori, Kazuhiro Yamamoto, Takefumi Ito, et al.Investigational New Drugs|March 26, 2024
KEYNOTE-434 part B: A phase 1 study evaluating the combination of epacadostat, pembrolizumab, and chemotherapy in Japanese patients with previously untreated advanced non-small-cell lung cancerNoboru Yamamoto, Miyako Satouchi, Toshihiko Doi, et al.Investigational New Drugs|March 27, 2024
The suppression of cell motility through the reduction of FAK activity and expression of cell adhesion proteins by hAMSCs secretome in MDA-MB-231 breast cancer cellsFatemeh Safari, Setareh Bararpour, Fatemeh Omidi ChomachaeiInvestigational New Drugs|August 17, 2023
Clinical characteristics of liver injury induced by immune checkpoint inhibitors in patients with advanced biliary tract carcinomaZhao Gao, Shikai Wu, Yinmo Yang, et al.Investigational New Drugs|August 12, 2023
Efficacy, safety, and cost-minimization analysis of axicabtagene ciloleucel and tisagenlecleucel CAR T-Cell therapies for treatment of relapsed or refractory follicular lymphomaButhainah GhanemInvestigational New Drugs|January 25, 2024
Phase 1 trial of navitoclax and sorafenib in patients with relapsed or refractory solid tumors with hepatocellular carcinoma expansion cohortOluwadunni E Emiloju, Jun Yin, Emily Koubek, et al.Investigational New Drugs|December 1, 2023
Phase I/II trial of BMS-986,205 and nivolumab as first line therapy in hepatocellular carcinomaJasmine C Huynh, May Cho, Arta Monjazeb, et al.Investigational New Drugs|December 8, 2023
Clinical characteristics, diagnosis, treatment, and prognosis of nivolumab induced gastritisHaibo Lei, Wei Sun, Xiang Liu, et al.Pageof 372